louisiana semaglutide gastrointestinal obstruction attorney law firm in gastric intestinal glp-1 gastric intestinal obstruction in louisiana Ozempic GLP-1 Lawsuit & Gastroparesis louisiana semaglutide bowel obstruction legal – kentucky semaglutide digestive blockage lawyer

Scientific opinion on oat beta-glucans and reduction of the post-prandial glucose peak, positive opinion adopted 28 January 2026

We were a small team moving at full speed, and that pressure pushed me to grow faster than I ever imagined

Immune and Non-immune Interactions in the Pathogenesis of Androgenetic Alopecia

A large retrospective cohort study published in JAMA Oncology evaluated more than 86,000 adults with obesity and found that individuals taking GLP-1 receptor agonists experienced a 17% lower overall risk of developing 13 out of 14 obesity-associated cancers compared with non-users, including a: 25% reduction in endometrial cancer

Research on rebound weight gain after discontinuation of GLP-1 drugs shows that many users regain weight within a timeframe similar to their usage period